Supported by Korean Society of Internal Medicine Research Fund(2012);the Seoul National University College of Medicine Research Fund(2011)
AIM: To evaluate the anti-tumor effect of clobenpropit, which is a specific H3 antagonist and H4 agonist, in combination with gemcitabine in a pancreatic cancer cell line.
This project was supported by grants from the National Natural Science Foundation of China (30572176 and 30600757) and the Zhejiang Provincial Natural Science Foundation of China (R303779)
Project partly supported by the Scientific Funds of CAO Guang-Biao in Zhejiang University.
AIM: The effect of clobenpropit on regional cerebral blood flow (rCBF) was investigated in the rat hippocampus. METHODS: rCBF was determined in the hippocampus by the hydrogen clearance method. The blood pressure was ...
AIM:The effect of histamine H3-receptor antagonist, clobenpropit (VUP9153) on spatial memory deficits induced by scopolamine was investigated in rats. METHODS:Eight-Arm radial maze performance was used to measure spat...